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with resection of malignancies
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Antônio Eduardo Zerati, MD,a and Inês Nobuko Nishimoto, PhD,c São Paulo, Brazil
Background: Patients with tumors in the limbs who undergo surgical treatment may have involvement of major
vessels. Major arteries are always reconstructed for limb salvage. Major veins may be reconstructed to avoid the onset
of venous hypertension signs and symptoms. The objective of this study was to analyze the results from surgical
treatment of a sample of patients who underwent lower limb venous reconstructions associated with the resection of
malignant tumors.
Methods: Follow-up was performed of 17 patients with malignant tumors involving major vessels in the lower limbs. The
median length of follow-up was 22 months. Venous reconstruction concomitant to arterial reconstruction was performed
in 15 patients, and an isolated venous reconstruction was performed in 2 patients. The venous substitutes used were the
contralateral long saphenous vein (n  12), expanded polytetrafluoroethylene prosthesis (n  3), and Dacron prosthesis
(n  2).
Results: Vascular complications occurred in seven patients: three occlusions of the venous graft, edema in seven patients,
and one rupture of the arterial graft. The primary 2- and 5-year patency rates of venous reconstructions were 79.3% and
79.3%, respectively. Nonvascular complications occurred in six patients: neurological deficit (n  3), partial necrosis of
the flap (n  2), wound infection (n  1), hematoma (n  1), and enteric fistula (n  1). Eight patients were still alive
and disease free, although one of them underwent above-knee amputation as a result of local disease recurrence. One
patient experienced regional disease recurrence and is undergoing chemotherapy. Eight patients died due to pulmonary
metastases. The 2- and 5-year overall survival rates were 58.6% and 42.4%, respectively. The 2- and 5-year thrombosis-free
survival rates were 51.9% and 35.2%, respectively.
Conclusions: Lower limb venous reconstructions associated with tumor resection in this study gave good functional
results, although the prognosis for these patients had been unfavorable. The saphenous vein is a suitable substitute.
(J Vasc Surg 2006;44:1046-50.)Up to the 1970s, patients with neoplasia in the extrem-
ities with involvement of the vascular bundle frequently had
to undergo amputation of the limb. Progress in surgical
procedures and the advent of multidisciplinary approaches
have allowed tumor resection to be performed with an
adequate safety margin, thus salvaging the limb1-3 with
good functional ability.
When the main artery is resected with the tumor mass,
there is no doubt regarding the need for its reconstruction,
because of the risk of severe ischemia and limb loss. How-
ever, there is no consensus in relation to venous reconstruc-
tion, regarding either the need to do it or the support
measures to be used. The biggest sample published con-
tains 15 patients,4 although there are no objective data
(imaging examinations) for analyzing the patency of the
reconstructions.
The objective of this study was to analyze the results
from surgical treatment of a large sample of patients who
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1046underwent lower limb venous reconstruction, considering
the primary patency, vascular and nonvascular complica-
tions, tumor recurrence, and patient survival.
MATERIALS AND METHODS
Seventeen patients who underwent operations because
of malignant tumors that had involved major arteries
and/or veins in the lower limbs were followed up from
September 1997 to January 2006. The length of follow-up
ranged from 2 to 96 months, with a median of 22 months.
Thirteen patients were women and four were men, with
ages ranging from 15 to 91 years (median, 38 years). With
regard to prior treatment for the tumor, six patients had not
undergone any type of therapy. Separate or comprehensive
previous treatments had included surgery, chemotherapy,
and radiotherapy. Seven patients had already undergone
operations, seven had had chemotherapy, and six had had
radiotherapy. The sites for the neoplasia were soft tissue in
the thigh (n 8), pelvis (n 2), fibula (n 2), femur (n
2), inguinal nodes (n  2), and vulva (n  1).
Upon clinical vascular examination, five patients pre-
sented with alterations: four patients presented edema at
the impaired limb, and one of them did not present popli-
teal and tibial arterial pulses. Another patient also did not
present popliteal and tibial arterial pulses.
With regard to complementary examinations, all pa-
tients underwent computerized tomography or nuclear
magnetic resonance, in which the tumoral mass was always
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resected vessels. The patients who had femoral-popliteal
obstruction underwent lower limb magnetic resonance an-
giography, which demonstrated obstruction of the superfi-
cial femoral artery and refilling of the popliteal and tibial
arteries, in addition to the absence of parietal irregularities
in these segments.
En-bloc resection of the vessels involved by the tumor
was chosen by the oncology surgeon on the basis of the
operative findings, which brought out evidence of agglom-
eration or adherence to the tumoral mass. The procedure
was indicated in the cases for which vascular resection
would be appropriate from an oncologic point of view and
there were no other areas of tumor that were not resectable
or where the resectability would be in doubt.
Venous reconstruction was performed routinely, ex-
cept when the stump distal to the tumoral bloc was oc-
cluded or when the vascular resection was performed in a
bundle that was considered nonessential. Arterial recon-
struction was always performed.
Venous and arterial reconstructions were performed
concomitantly in 15 patients: femoral-popliteal (n  7),
external iliac–common femoral (n  3), external iliac–
superficial femoral (n  2), common iliac–external iliac
(n 1), common femoral–popliteal (n 1), and popliteal–
posterior tibial (n  1). An isolated venous reconstruction
was performed in two patients: femoral–external iliac (n 
1) and popliteal-femoral (n  1).
The vascular substitutes used for the venous recon-
structions were the contralateral long saphenous vein (n 
Table I. Epidemiologic characteristics, site, histology type
nonvascular complications
Patient
No.
Sex/age
(y) Site Type Impaired
1 F/29 Thigh Fibrohistiocytoma Fem v
2 F/91 Vulva Squamous cell
carcinoma
Fem v
3 F/16 Fibula Osteosarcoma Popliteal v
4 M/24 Femur Osteosarcoma Fem v  su
5 M/23 Thigh Fibrosarcoma Fem v  su
6 F/15 Thigh Synovial sarcoma Fem v  su
7 F/39 Thigh Hemangiopericytoma Fem v  co
8 F/65 Inguinal
nodes
Malignant melanoma Fem v  co
9 F/59 Inguinal
nodes
Malignant melanoma Fem v  co
10 F/23 Thigh Synovial sarcoma Fem v  su
11 F/27 Thigh Fibrohistiocytoma Fem v  su
12 F/62 Fibula Synovial sarcoma Popliteal v
13 F/55 Pelvis Leiomyosarcoma Ext iliac v 
14 M/52 Pelvis Liposarcoma Ext iliac v 
15 M/42 Thigh Synovial sarcoma Fem v  su
16 F/21 Femur Osteosarcoma Fem v  su
17 F/38 Thigh Leiomyosarcoma Fem v  su
Fem, Femoral; sup, superficial; com, common; ext, external; v, vein; a, artery12), nonringed expanded polytetrafluoroethylene prosthe-sis (n  3), and Dacron prosthesis (DuPont, Wilmington,
Del; n  2). For the patients who underwent arterial and
venous reconstructions, the same substitute was used for
both grafts. In the cases in which the long saphenous vein
was used, the arterial grafts were constructed by using a
reversed vein.
Tissue coverage of resected areas and associated vascu-
lar grafts was provided by local muscle/skin flaps. Prophy-
lactic antibiotic therapy and vacuum drains were used in all
cases. No reconstruction of nerves was performed in the
patients who underwent combined resection.
The histologic types encountered were synovial sar-
coma (n 4), osteosarcoma (n 3), fibrohistiocytoma (n
2), leiomyosarcoma (n 2), malignant melanoma (n 2),
squamous cell carcinoma (n  1), fibrosarcoma (n  1),
hemangiopericytoma (n  1), and liposarcoma (n  1).
During the hospital stay, prophylaxis for deep vein
thrombosis, consisting of low-molecular-weight heparin,
was administered to all patients. After discharge from the
hospital, no drugs aimed at prolonging the patency of the
grafts were administered, such as antiplatelet aggregation
drugs, anticoagulants, or peripheral vasodilators.
In Table I, the characteristics of the operated patients
are reported. The follow-up of the patients was performed
by means of outpatient returns, at which a clinical exami-
nation and duplex surveillance were performed to study the
patency of the grafts. Duplex mapping was performed every
6 months during the first year after the operation and
annually thereafter or upon suspicion of a complication
aired vessels, vascular substitute, and vascular and
ls Substitute Vascular Nonvascular
SV — —
PTFE — Flap necrosis
SV/SV — Neurologic deficit
a SV/SV — —
a SV/SV Edema —
a SV/SV — —
m a SV/SV Edema —
m a Dacron/Dacron Venous occlusion
 edema
Flap necrosis 
neurologic deficit
m a PTFE/PTFE Venous occlusion
 edema
Enteric fistula 
neurologic deficit
a SV/SV Arterial rupture
 edema
Wound infection
a SV/SV — —
SV/SV — —
PTFE/PTFE — —
Dacron/Dacron Venous occlusion
 edema
—
a SV/SV Edema Hematoma
a SV/SV — —
a SV/SV — —
aphenous vein; PTFE, prosthesis of expanded polytetrafluoroethylene., imp
vesse
 a
p fem
p fem
p fem
m fe
m fe
m fe
p fem
p fem
 a
a
a
p fem
p fem
p femregarding the vascular grafts (occlusion).
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Eight patients did not experience any type of com-
plication during the follow-up. Vascular complications
occurred in seven patients. Three patients had venous
graft occlusions. All of these cases presented with an
abrupt onset of swelling in the affected limb, and duplex
mapping confirmed the diagnosis. The occlusions oc-
curred at 2, 3, and 8 months after surgery. In all cases,
the substitute used was prosthetic, and the patients were
treated by means of systemic anticoagulation in addition
to elastic support. No patient progressed with hyperpig-
mentation, eczema, or venous claudication in the lower
limb. The primary 2- and 5-year patency rates of venous
reconstructions were 79.3% and 79.3%, respectively (Fig 1).
One patient who underwent venous and arterial re-
constructions progressed with infection of the operative
wound and was readmitted to the hospital to receive
endovenous systemic antibiotic therapy but experienced
rupture of the arterial graft on the 21st day after the
operation. During exploratory surgery, the location of
the rupture was identified, and this graft was ligated with
Prolene 5-0 (Ethicon, Johnson & Johnson, São José dos
Campos, São Paulo, Brazil). It was not possible to iden-
tify the venous graft, which had a deeper location, but
postoperative duplex mapping showed that the venous
graft was patent and continued to be so throughout the
follow-up. This patient had had previous femoral-popli-
teal obstruction, and, despite the vascular ligature, there
was no severe ischemia of the limb. All remaining arterial
grafts were patent. The primary 2- and 5-year patency
rates of arterial reconstructions were 93.1% and 93.1%,
respectively.
Limb edema was the most frequent vascular compli-
cation, and this occurred in seven patients, of whom four
had previously experienced some degree of edema. All
these patients were treated on an outpatient basis by
means of manual lymphatic drainage sessions together
with inelastic bandaging during the first 3 weeks. After
this, the manual drainage was associated with elastic
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Fig 1. Primary patency of venous reconstructions.compression, and, after the condition stabilized, only theelastic support was used. Only one patient, who already
had substantial preoperative lymphedema, did not im-
prove.
Nonvascular complications were detected in six pa-
tients: neurologic deficit (n  3), partial necrosis of the
flap (n  2), wound infection (n  1), hematoma (n 
1), and enteric fistula (n 1). From a functional point of
view, four had moderate functional limitation in the
operated limb. One patient already had significant
lymphedema in the affected limb, and it worsened after
the operation. In another three patients, the limitation
was caused by combined resection of nerves (fibular in
one case and femoral in two cases), and one required an
orthosis to be able to walk.
There was no death during the intraoperative or
hospitalization periods. Eight patients were still alive and
disease free after a median of 48 months of follow-up,
although one of these underwent above-knee amputa-
tion because of local tumor recurrence after 11 months.
One patient had regional disease recurrence and is un-
dergoing chemotherapy after 96 months. Eight patients
died as a result of pulmonary metastases after a median of
20.5 months. The 2- and 5-year overall survival rates
were 58.6% and 42.4%, respectively (Fig 2). The 2- and
5-year thrombosis-free survival rates were 51.9% and
35.2%, respectively (Fig 3).
DISCUSSION
The treatment of patients with malignant neoplasia
in the lower limbs has been continually improved over
the last 30 years. Because of the development of imaging
examinations (with the possibility of early diagnosis),
effective adjuvant therapies, and better operative tech-
niques, the concept of tumor irresectability is becoming
increasingly restricted, such that vascular invasion no
longer represents an obstacle to resection of these tu-
mors. Among the indications for primary amputation of
a limb, the following can be considered: patients with
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Fig 2. Overall survival of patients treated with en-bloc vessel
resection and reconstruction in the lower limbs.large infected tumors and patients with tumors that are
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nervous bundle and the bone. These patients are candi-
dates for extensive resection, although it is impossible to
accomplish adequate coverage for the bleeding areas.
Considering the high risk of severe ischemia and limb
loss after arterial ligature, reconstruction of the artery is
always indicated. In cases of neoplasm resection, in addition
to the trunk vessels, a large part of the collateral circulation
is resected for oncologic purposes, thus corroborating the
need for the arterial reconstruction.5-12
In our sample, there was only one arterial graft compli-
cation, which consisted of rupture consequent to wound
infection, despite the use of an autologous substitute. This
patient had previously had femoral-popliteal obstruction,
and there was no ischemia of the limb, despite the ligature
of the graft.
Venous reconstructions associated with the resection of
neoplasia are less prominent in the literature than arterial
reconstructions. Sometimes the samples of venous recon-
struction do not have follow-up data.2,4,6,12 Venous liga-
ture does not interfere with the preservation of the
limb,1,2,13 and therefore reconstructions are not always
performed. In addition to this, after ligature, some authors
have reported achieving satisfactory control over the edema
during its acute period via limb elevation and elastic sup-
port.2,5,7 Nonetheless, over the long term, a patient sub-
mitted to venous resection without reconstruction may
experience severe edema, claudication, hyperpigmentation,
and eczema on the affected limb.13 In such patients, the
deficit in the lymphatic drainage8 is another significant
factor that generates edema.
A variety of venous substitutes have been described
(Table II). The use of a prosthetic substitute has been
predominant,4,5,7,8,14 although the best patency rates have
been obtained from samples in which autologous substi-
tutes prevailed.9-11 Moreover, infection of the vascular
graft has been more associated with prosthetic substi-
tutes.4,5,8 For these reasons, we gave preference to autolo-
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Fig 3. Thrombosis-free survival of patients treated with en-bloc
vessel resection and reconstruction in the lower limbs.gous substitutes, such that the contralateral long saphenousvein was used in 12 of the 17 reconstructions. In the
segments where there was some degree of caliber discrep-
ancy, end-to-side anastomoses were performed with good
graft functioning. In the cases in which there was great
caliber discrepancy with the saphenous vein, or in its ab-
sence (previous saphenectomy), we decided on prosthetic
substitution. One technical alternative in these cases would
be the use of a panel graft or spiral graft of autologous
superficial veins, such as the long saphenous vein itself or
the short saphenous vein and veins from the upper limbs.
Other autologous substitutes described have been the fem-
oral vein12 and axillary vein,1 although we believe that
resection of veins in the deep vein system may cause mor-
bidity in that limb.
The patency rates for venous reconstructions are lower
than for arterial ones.11,12,14 Some authors have used ad-
juvant measures such as the construction of an arterio-
venous fistula8 or oral anticoagulation treatment,8,9 with
the aim of improving the patency rates for venous recon-
structions, although without success. The arterial patency
can be detected by means of clinical examination, although
complementary imaging examinations are needed for ascer-
taining whether venous patency has been achieved. Some
authors have performed phlebography5,7,8 as a component
of the follow-up, but we prefer duplex mapping9,11 because
of its noninvasive nature and high accuracy.
In our sample, there were no cases of occlusion of the
venous graft with an autologous substitute, whereas occlu-
sion occurred in three of the five cases of prosthetic grafts.
Nevertheless, these occlusions occurred after an average of
4 months and, therefore, without increasing morbidity
during the acute postoperative period.
Edema in the affected limb was the most frequent
vascular complication1,2,4,5,7 and was seen in seven pa-
tients. This complication had lymphatic and venous com-
Table II. Venous reconstructions
Author n Substitutes Patency
Fortner1 (1977) 3 Saphenous 2/axillary 1 ?
Imparato2 (1978) 3 Saphenous ?
Nambisan5 (1987) 6 PTFE 33%
Steed6 (1987) 1 Saphenous ?
Karakousis7 (1989) 9 PTFE 0%
Kawai8 (1996) 7 PTFE 5/saphenous 2 14%
Koperna9 (1996) 13 Saphenous 8/PTFE
4/Dacron 1
77%
Karakousis4 (1996) 15 PTFE 14/saphenous 1 ?
Hohenberger10 (1999) 10 Saphenous 6/PTFE 4 72%
Bonardelli11 (2000) 5 Saphenous 3/
transposition 2
100%
Leggon12 (2001) 8 Saphenous 5/femoral
2/Dacron 1
?
Schwarzbach14 (2005) 12 PTFE 10/saphenous 2 58%
Present study 17 Saphenous 12/PTFE
3/Dacron 2
82%
n, Number of venous reconstructions; ?, without complementary examina-
tions; PTFE, polytetrafluoroethylene.ponents and was caused by the extensive vascular resection
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logic safety margins. This was, in some cases, associated
with occlusion of the graft. Clinical treatment was satisfac-
tory in all of these patients, with the exception of one case
in which there was substantial preoperative lymphedema.
Over the period of this study, 106 patients with soft
tissue sarcomas in the lower extremities underwent opera-
tions in our institution. Ten of them underwent primary
amputation of the limb. The length of follow-up for the
patients who underwent primary amputation ranged from
1 to 96 months, with a median of 13.5 months. The
estimated 2- and 5-year survival rates were, respectively,
30% and 30%. Although the group of patients who under-
went vascular reconstruction was not absolutely compara-
ble with the group of patients who underwent primary
amputation (the first group also contained patients with
other malignant neoplasias, as well as soft tissue sarcomas),
the survival rates (58.6% and 42.4%) presented were better
than those for the group of amputees, with the advantage of
having preserved the limb.
The occurrence of a functional deficit in the limb was
expected and discussed during the preoperative period with
some patients; however, no one accepted primary amputa-
tion as the first alternative of treatment. In patients for
whom a functional deficit in the limb is expected, which is
principally caused by combined resection of nerves, primary
amputation is becoming less and less accepted, because of
the emergence of orthoses together with the difficulty in
accepting loss of the limb.
CONCLUSIONS
Lower limb venous reconstructions associated with
tumor resection in this study gave good functional results,
although the prognosis for these patients had been unfa-
vorable. The saphenous vein is a suitable substitute.
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